GLP-1s, Medicare & Medicaid: BALANCE Model Explained
Medicare & Medicaid Expansion of GLP-1 Access: A New Era for Diabetes and Weight Management February 29, 2024 Washington D.C. – Access to glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs initially developed for type 2 diabetes but increasingly used for weight management, is undergoing a significant shift within Medicare and Medicaid. The Centers … Read more